期刊
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
卷 48, 期 11, 页码 5118-5124出版社
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
DOI: 10.1167/iovs.07-0302
关键词
-
PURPOSE. To test the activity of a synthetic theta-defensin, retrocyclin ( RC)- 2, in a murine herpes simplex virus ( HSV)-1 keratitis model. METHODS. The in vitro antiviral activity of RC- 2 against HSV- 1 KOS was determined by yield reduction and viral inactivation assays. Efficacy in an experimental murine HSV- 1 keratitis model was tested using pre- or postinfection treatment with 0.1% peptide in PBS with or without 2% methylcellulose. Viral titers in the tear film were determined by plaque assay. RESULTS. RC- 2 inhibited HSV- 1 KOS in vitro with an EC50 of 10 mu M (similar to 20 mu g/mL) in yield- reduction assays, but was not directly virucidal. RC- 106 ( a less active analogue) did not inhibit HSV- 1 KOS in culture. Incubating the virus with RC- 2 or applying the peptide in 2% methylcellulose to the cornea before viral infection significantly reduced the severity of ocular disease, but postinfection treatment with 0.1% RC- 2 in PBS with or without 2% methylcellulose did not. Viral titers were significantly reduced on some days after infection in the preincubation and prophylaxis groups. CONCLUSIONS. RC- 2 was active against HSV- 1 KOS in cultures and showed protective activity in vivo when used in a prophylactic mode, but the peptide showed limited activity in a postinfection herpes keratitis model. These findings support data obtained from experiments with HIV-1, HSV-2, and influenza A, indicating that RCs inhibit the entry of viruses rather than their replication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据